Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-05

Study Completion Date

2023-03-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study tailors a shared decision making intervention for lung cancer screening in persons living with human immunodeficiency virus (HIV). Information collected in this study may help doctors better understand how to perform lung cancer screening in persons living with HIV, so as to enhance shared decision making in persons living with HIV.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission

NCT02044484

HIV

COMPLETED NA

Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions

NCT03721796

Newly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating Oncologist

TERMINATED

Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV

NCT03289676

HIV/AIDS

COMPLETED PHASE1

Attitudes and Beliefs and the Steps of HIV Care

NCT00749840

Human Immunodeficiency Virus Infections

COMPLETED

Behavioral Intervention to Enhance HIV Test/Treat

NCT01752777

HIV/AIDS

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OUTLINE:

AIM I: Participants attend a focus group over 1-1.5 hours providing feedback on refining potential methods of shared decision making (SDM).

AIM II: Participants receive the SDM intervention developed in Aim I and provide feedback. Participants may attend a telephone interview over 45 minutes 1 month later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aims I-II

AIM I: Participants attend a focus group over 1-1.5 hours providing feedback on refining potential methods of SDM.

AIM II: Participants receive the SDM intervention developed in Aim I and provide feedback. Participants may attend a telephone interview over 45 minutes 1 month later.

Behavioral Intervention

Intervention Type BEHAVIORAL

Receive SDM intervention

Discussion (focus group)

Intervention Type OTHER

Attend focus group

Discussion (feedback on SDM)

Intervention Type OTHER

Provide feedback on SDM

Interview

Intervention Type OTHER

Attend a telephone interview

Survey Administration

Intervention Type OTHER

Ancillary studies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral Intervention

Receive SDM intervention

Intervention Type BEHAVIORAL

Discussion (focus group)

Attend focus group

Intervention Type OTHER

Discussion (feedback on SDM)

Provide feedback on SDM

Intervention Type OTHER

Interview

Attend a telephone interview

Intervention Type OTHER

Survey Administration

Ancillary studies

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Behavior Conditioning Therapy Behavior Modification Behavior or Life Style Modifications Behavior Therapy Behavioral Interventions Behavioral Modification Behavioral Therapy Behavioral Treatment Behavioral Treatments Discuss Discuss

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* AIM I: Patients with human immunodeficiency virus (PWH) enrolled in the local UW HIV cohort and primary providers at Madison Clinic and other Seattle-based clinics serving PWH
* AIM I: Using proposed United States Preventive Services Task Force (USPSTF) guidelines, participants enrolled in the registry who are current or former smokers, report \>= 20 pack-years smoking history, and \>= 50 years old (n=165) will be eligible for recruitment
* AIM I: Clinicians (medical doctors, physicians assistants and nurse practitioners) who provide primary care for PWH (n=48) will be eligible
* AIM II: PWH who are eligible for lung cancer screening (LCS) based on proposed USPSTF criteria

Exclusion Criteria

* Those found to be ineligible for LCS on coordinator review
* Are non-English speaking or have cognitive dysfunction that would prevent participation in SDM

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes